Literature DB >> 13209303

The dissemination of 17D yellow fever vaccine in Africans in Kenya in relation to the interpretation of results of protection-test surveys.

W H LUMSDEN.   

Abstract

The extent of dissemination of 17D yellow fever vaccine among the population of Kenya, especially among Africans, is estimated, largely from information in the records of the Kenya Medical Department. The total recorded vaccinations of Africans between 1941 and 1951 amount to about 379,000, representing 7.2% of the African population in 1948; it is, however, possible that the actual number of vaccinations is considerably higher. At Mombasa, 78,000 persons of races other than Africans were given routine inoculation over the same period.After a study of the economy of use of vaccine, the author discusses the protection-test surveys performed before 1951 and during that year in relation to the dissemination of vaccine. It is tentatively concluded that natural infection of man with yellow fever is rare in both Kenya and Tanganyika.

Entities:  

Keywords:  VACCINES AND VACCINATION

Mesh:

Substances:

Year:  1954        PMID: 13209303      PMCID: PMC2542196     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  A review of the results of yellow fever protection-tests on the sera of primates from Kenya.

Authors:  A J HADDOW
Journal:  Ann Trop Med Parasitol       Date:  1952-09

2.  Immunity to yellow fever nine years after vaccination with 17D vaccine.

Authors:  G W A DICK; F L GEE
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-07       Impact factor: 2.184

3.  Further studies on the distribution of immunity to yellow fever in east and south-east Africa.

Authors:  K C SMITHBURN; K GOODNER
Journal:  Ann Trop Med Parasitol       Date:  1949-10
  3 in total
  1 in total

1.  [Yellow fever in the Federation of Ethiopia & Eritrea; present-day epidemiological data].

Authors:  M A CHABAUD; M OVAZZA
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.